TFX

MKT CAP:$6B

Teleflex Incorporated

Market Cap

$6B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$136.65+$14.25 (+11.64%)

Apr 23, 2026

Company Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that ...

CEO

Stuart A. Randle

IPO Date

Mar 17, 1980

Website

www.teleflex.com

Key Metrics TTM

Revenue

$3.2B

+5.4% YoY

Net Income

-$328M

EPS (Diluted)

-$7.35

Free Cash Flow

$264M

Revenue / Share

$72.11

Gross Margin

53.7%

Operating Margin

4.4%

Net Margin

-10.3%

FCF Margin

8.3%

P/S

1.9x

P/E

—

Earnings Reports

Q4 2025

May 7, 2026

PENDING

Q3 2025

Nov 6, 2025

$913M+19.4%EPS -$9.24

Q2 2025

Jul 31, 2025

$781M+4.2%EPS $2.77

Q1 2025

May 1, 2025

$701M-5.0%EPS $2.07

FY 2024

Feb 28, 2025

$3.0B+2.4%EPS $1.48

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$762M	$420M	$155M
Q1 22	$642M	$346M	$104M
Q2 22	$705M	$389M	$135M
Q3 22	$687M	$374M	$132M
Q4 22	$758M	$422M	$129M
Q1 23	$711M	$391M	$115M
Q2 23	$743M	$408M	$144M
Q3 23	$746M	$416M	$165M
Q4 23	$774M	$431M	$82M
Q1 24	$738M	$416M	-$5M
Q2 24	$750M	$416M	$117M
Q3 24	$764M	$430M	$149M
Q4 24	$795M	$440M	-$110M
Q1 25	$701M	$389M	$126M
Q2 25	$781M	$431M	$155M
Q3 25	$913M	$452M	-$30M

Valuation

Quarter	P/S	P/E
Q4 21	2.2x	12.4x
Q1 22	2.1x	12.4x
Q2 22	2.2x	11.8x
Q3 22	2.2x	14.6x
Q4 22	2.2x	16.6x
Q1 23	2.1x	16.7x
Q2 23	2.1x	16.4x
Q3 23	2.0x	15.0x
Q4 23	2.0x	17.0x
Q1 24	2.0x	20.5x
Q2 24	2.0x	22.9x
Q3 24	2.0x	25.4x
Q4 24	2.0x	86.7x
Q1 25	2.0x	40.4x
Q2 25	2.0x	31.5x
Q3 25	1.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$201M	$182M
Q1 22	$62M	$49M
Q2 22	$40M	$20M
Q3 22	$142M	$122M
Q4 22	$98M	$72M
Q1 23	$84M	$62M
Q2 23	$86M	$69M
Q3 23	$201M	$177M
Q4 23	$139M	$111M
Q1 24	$111M	$73M
Q2 24	$91M	$57M
Q3 24	$231M	$210M
Q4 24	$202M	$170M
Q1 25	$73M	$43M
Q2 25	$8M	-$27M
Q3 25	$108M	$78M

Capital Expenditures

Quarter	CapEx
Q4 21	$20M
Q1 22	$13M
Q2 22	$19M
Q3 22	$20M
Q4 22	$27M
Q1 23	$22M
Q2 23	$18M
Q3 23	$24M
Q4 23	$28M
Q1 24	$38M
Q2 24	$35M
Q3 24	$21M
Q4 24	$32M
Q1 25	$30M
Q2 25	$35M
Q3 25	$30M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+7.1%	-1.5%
Q1 22	+1.2%	+1.4%
Q2 22	-1.3%	-2.6%
Q3 22	-1.9%	+20.7%
Q4 22	-0.5%	+3.7%
Q1 23	+10.8%	+10.7%
Q2 23	+5.5%	+5.3%
Q3 23	+8.7%	+4.8%
Q4 23	+2.1%	+9.9%
Q1 24	+3.8%	+24.6%
Q2 24	+0.9%	+5.5%
Q3 24	+2.4%	+5.8%
Q4 24	+2.8%	+31.0%
Q1 25	-5.0%	-22.6%
Q2 25	+4.2%	-1.1%
Q3 25	+19.4%	+53.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$6M	0.8%
Q1 22	$5M	0.8%
Q2 22	$7M	1.1%
Q3 22	$7M	1.0%
Q4 22	$7M	1.0%
Q1 23	$7M	1.0%
Q2 23	$7M	0.9%
Q3 23	$0	0.0%
Q4 23	$9M	1.2%
Q1 24	$7M	1.0%
Q2 24	$9M	1.1%
Q3 24	$8M	1.0%
Q4 24	$8M	1.0%
Q1 25	$8M	1.1%
Q2 25	$7M	0.9%
Q3 25	$8M	0.9%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 21	$36M	—	$228M
Q1 22	$36M	—	$204M
Q2 22	$37M	—	$217M
Q3 22	$38M	—	$210M
Q4 22	$43M	—	$233M
Q1 23	$41M	$233M	—
Q2 23	$39M	—	$223M
Q3 23	$38M	—	$213M
Q4 23	$36M	—	$261M
Q1 24	$37M	$381M	—
Q2 24	$41M	—	$251M
Q3 24	$39M	—	$247M
Q4 24	$45M	—	$255M
Q1 25	$36M	—	$223M
Q2 25	$39M	—	$215M
Q3 25	$57M	—	$282M

Revenue by Geography

Quarter	Americas Segment	Asia	Emea	Oem
Q4 21	$452M	$79M	$165M	$67M
Q1 22	$378M	$69M	$137M	$58M
Q2 22	$413M	$77M	$145M	$70M
Q3 22	$405M	$82M	$128M	$71M
Q4 22	$458M	$78M	$148M	$74M
Q1 23	$412M	$79M	$143M	$77M
Q2 23	$425M	$87M	$148M	$84M
Q3 23	$428M	$93M	$143M	$82M
Q4 23	$451M	$88M	$152M	$83M
Q1 24	$406M	$84M	$160M	$88M
Q2 24	$427M	$87M	$147M	$89M
Q3 24	$433M	$98M	$150M	$83M
Q1 25	$476M	$74M	$151M	—
Q2 25	$526M	$89M	$166M	—
Q3 25	$556M	$123M	$234M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$467M	$0	$467M
Q2 22	$308M	$0	$308M
Q3 22	$397M	$0	$397M
Q4 22	$292M	$0	$292M
Q1 23	$264M	$0	$264M
Q2 23	$251M	$0	$251M
Q3 23	$881M	$0	$881M
Q4 23	$223M	$0	$223M
Q1 24	$237M	$0	$237M
Q2 24	$239M	$0	$239M
Q3 24	$243M	$0	$243M
Q4 24	$290M	$0	$290M
Q1 25	$284M	$0	$284M
Q2 25	$254M	$0	$254M
Q3 25	$354M	$0	$354M
Q4 25	$393M	$0	$393M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	47M	-0.1%	+0.2%
Q1 22	47M	-0.0%	-0.0%
Q2 22	47M	-0.1%	-0.2%
Q3 22	47M	-0.2%	-0.4%
Q4 22	47M	-0.1%	-0.4%
Q1 23	47M	+0.1%	-0.2%
Q2 23	47M	+0.1%	-0.0%
Q3 23	47M	-0.1%	+0.1%
Q4 23	47M	+0.0%	+0.2%
Q1 24	47M	+0.2%	+0.2%
Q2 24	47M	-0.1%	+0.1%
Q3 24	47M	-0.7%	-0.6%
Q4 24	46M	-1.4%	-2.0%
Q1 25	46M	-1.0%	-3.1%
Q2 25	46M	0.0%	-3.0%
Q3 25	44M	-3.7%	-5.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$54.4K	14K
Q1 22	$45.8K	14K
Q2 22	$50.3K	14K
Q3 22	$49.1K	14K
Q4 22	$48.9K	16K
Q1 23	$45.9K	16K
Q2 23	$48.0K	16K
Q3 23	$48.2K	16K
Q4 23	$53.4K	15K
Q1 24	$50.9K	15K
Q2 24	$51.7K	15K
Q3 24	$52.7K	15K
Q4 24	$56.4K	14K
Q1 25	$49.7K	14K
Q2 25	$55.4K	14K
Q3 25	$64.8K	14K

Revenue / Employee